PharmiWeb.com - Global Pharma News & Resources
06-Jun-2019

Women’s Health Therapeutics Market 2019 | Global Trend, Segmentation And Opportunities Forecast To 2024

New York, June 06, 2019: Global women’s health therapeutics market is segmented based on the type as, Infection, Pregnancy, and Oncology. Global women’s health therapeutics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional women’s health therapeutics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Market Research Engine has published a new report titled as “Women’s Health Therapeutics Market Size, By Product (Infection, Pregnancy, Oncology [Cervical Cancer, Uterine Cancer, Ovarian Cancer, Vaginal & Vulvar Cancer]), By Region, Market Analysis Report, Forecast 2018-2024.”

Browse Full Report: https://www.marketresearchengine.com/women-health-therapeutics-market

Rising prevalence of lifestyle associated accompanied with chronic disorders in women is majorly proliferating the women’s health therapeutics market size over the study time frame. Furthermore, increasing healthcare investment to diagnose infectious and cancer disease at early stage, pregnancy related complexities, and introduction of innovative & effective drugs is likely to propel industry size.

Increasing awareness relevant to menopause, infections, osteoporosis, and cancer is predicted to accelerate the industry growth. In addition, launch of new drug therapies by major industry players will further contribute in expansion of industry size over the next seven years. For instance, in March 2017, the U.S. Food and Drug Administration (FDA) approved Zejula by TESARO, that will be used for treating advanced ovarian cancer.

Competitive Rivalry

Global women’s health therapeutics market share consists of several players including Mylan, GlaxoSmithKline, Bayer; Novartis, Pfizer; TESARO, Bristol-Myers Squibb Company, F. Hoffmann-La Roche, AstraZeneca, and Teva Pharmaceutical.

The Women’s Health Therapeutics Market has been segmented as below:

Women’s Health Therapeutics Market, By Type

  • Infection
  • Pregnancy
  • Oncology
    • Cervical Cancer
    • Uterine Cancer
    • Ovarian Cancer
    • Vaginal & Vulvar Cancer

Women’s Health Therapeutics Market, By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The report covers:

  • Global women’s health therapeutics market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
  • Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global women’s health therapeutics market trends, with detailed analysis on consumer trends & manufacturer trends
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe
  • Competitive analysis of the industry players along with the overview on strategic management
  • Comprehensive company profiles of the major industry players

Report scope:

The global women’s health therapeutics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.

The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies. 

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Mylan, GlaxoSmithKline, Bayer; Novartis, Pfizer; TESARO, Bristol-Myers Squibb Company, F. Hoffmann-La Roche, AstraZeneca, and Teva Pharmaceutical.

Reasons to Buy this Report:

  • Gain comprehensive insights on the industry trends
  • Identify industry opportunities and key growth segments
  • Obtain complete market study on the women’s health therapeutics market
  • Facilitate strategy planning for your company based on the industry dynamics
  • Evaluate your competitor’s business segments and portfolios

Request Sample Report from here: https://www.marketresearchengine.com/women-health-therapeutics-market

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
        4.2.    Drivers
            4.2.1.    High prevalence of infectious diseases among women
            4.2.2.    Growing awareness
        4.3.    Restraints
            4.3.1.    High cost of therapies
        4.4.    Opportunities
            4.4.1.    Increasing investments
            4.4.2.    Introduction of new drug therapies
        4.5.    Challenges
            4.5.1.    Stringent regulations
  5.  Women’s Health Therapeutics Market, By Product
  6.  Competitive Landscape
  7.  Company Profile
     7.1.    Mylan
            7.1.1.    Company Overview
            7.1.2.    Product/Service Landscape
            7.1.3.    Financial Overview
            7.1.4.    Recent Developments
        7.2.    GlaxoSmithKline
            7.2.1.    Company Overview
            7.2.2.    Product/Service Landscape
            7.2.3.    Financial Overview
            7.2.4.    Recent Developments
        7.3.    Bayer
            7.3.1.    Company Overview
            7.3.2.    Product/Service Landscape
            7.3.3.    Financial Overview
            7.3.4.    Recent Developments
        7.4.    Novartis
            7.4.1.    Company Overview
            7.4.2.    Product/Service Landscape
            7.4.3.    Financial Overview
            7.4.4.    Recent Developments
        7.5.    Pfizer
            7.5.1.    Company Overview
            7.5.2.    Product/Service Landscape
            7.5.3.    Financial Overview
            7.5.4.    Recent Developments
        7.6.    TESARO
            7.6.1.    Company Overview
            7.6.2.    Product/Service Landscape
            7.6.3.    Financial Overview
            7.6.4.    Recent Developments
        7.7.    Bristol-Myers Squibb Company
            7.7.1.    Company Overview
            7.7.2.    Product/Service Landscape
            7.7.3.    Financial Overview
            7.7.4.    Recent Developments
        7.8.    F. Hoffmann-La Roche
            7.8.1.    Company Overview
            7.8.2.    Product/Service Landscape
            7.8.3.    Financial Overview
            7.8.4.    Recent Developments
        7.9.    AstraZeneca
            7.9.1.    Company Overview
            7.9.2.    Product/Service Landscape
            7.9.3.    Financial Overview
            7.9.4.    Recent Developments
        7.10.    Teva Pharmaceutical
            7.10.1.    Company Overview
            7.10.2.    Product/Service Landscape
            7.10.3.    Financial Overview
            7.10.4.    Recent Developments

Other Related Market Research Reports:

Vaccine Technologies Market Global Industry Analysis, Size, Share, Growth by 2024

Urinary Incontinence and Overactive Bladder Market Global Industry Analysis, Size, Share, Growth by 2024

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Editor Details

Last Updated: 07-Jun-2019